Table 2.
Association between positive changes in somatic depressive symptoms and mortality and recurrent MI in the intervention group after multivariable adjustment.
| Variables in model | HR | 95% CI | P |
|---|---|---|---|
| Changes in somatic depressive symptoms | 0.93 | 0.88–0.98 | 0.01 |
| Baseline somatic depressive symptoms | 1.04 | 0.98–1.11 | 0.19 |
| Age | 1.03 | 1.01–1.05 | 0.001 |
| Diabetes | 1.48 | 0.93–2.35 | 0.10 |
| Renal insufficiency | 1.49 | 0.75–2.96 | 0.25 |
| LVEF % | 0.98 | 0.96–1.00 | 0.04 |
| Creatinine | 1.33 | 1.07–1.65 | 0.01 |
| History of pulmonary disease | 1.81 | 1.09–2.99 | 0.02 |
| Prior MI | 1.44 | 0.89–2.32 | 0.13 |
| History of CHF | 1.30 | 0.74–2.31 | 0.36 |
| Prior TIA or stroke | 1.06 | 0.53–2.15 | 0.87 |
| CABG treatment of index MI | 1.00 | 0.53–1.88 | 0.99 |
| Use of vasodilators (non-ACE) | 0.97 | 0.59–1.59 | 0.90 |
ACE=angiotensin-converting enzyme; CABG=coronary artery bypass graft; CHF=congestive heart failure; LVEF=left ventricular ejection fraction; MI=myocardial infarction; TIA=transient ischemic attack.